SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-20-139275
Filing Date
2020-12-23
Accepted
2020-12-23 18:08:54
Documents
1
Period of Report
2020-03-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2039202-2_4seq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2039202-2_4seq1.xml 4/A 7403
  Complete submission text file 0001104659-20-139275.txt   8769
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 BROADWAY 3RD FLOOR NEW YORK NY 10038
Business Address
Jacobson Mark L. (Reporting) CIK: 0001805812 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37635 | Film No.: 201413851